Stockscreener 앱 받기
57.00
2.33%
1.30
시간 외 거래:
54.00
-3.00
-5.26%
전일 마감가:
$55.70
열려 있는:
$55.43
하루 거래량:
1.47M
Relative Volume:
1.76
시가총액:
$3.20B
수익:
$665.13M
순이익/손실:
$64.50M
주가수익비율:
49.82
EPS:
1.1442
순현금흐름:
$185.87M
1주 성능:
+7.20%
1개월 성능:
+17.89%
6개월 성능:
+73.57%
1년 성능:
+64.27%
1일 변동 폭
$54.61
$57.40
1주일 범위
$53.16
$57.65
52주 변동 폭
$29.16
$57.65
Supernus Pharmaceuticals Inc Stock (SUPN) Company Profile
명칭
Supernus Pharmaceuticals Inc
전화
301-838-2500
주소
9715 KEY WEST AVENUE, ROCKVILLE, MD
SUPN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SUPN
Supernus Pharmaceuticals Inc
|
57.00 | 3.12B | 665.13M | 64.50M | 185.87M | 1.1442 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Supernus Pharmaceuticals Inc Stock (SUPN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-09 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-07-30 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-02-19 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-09-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-01-03 | 재개 | Jefferies | Buy |
| 2021-12-01 | 재개 | Jefferies | Buy |
| 2021-04-13 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-06-16 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-06-15 | 재개 | Jefferies | Hold |
| 2019-11-08 | 다운그레이드 | Berenberg | Buy → Hold |
| 2019-11-07 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-11-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-11-12 | 재확인 | B. Riley FBR | Buy |
| 2018-01-18 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-12-28 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-12-04 | 업그레이드 | Janney | Neutral → Buy |
| 2017-11-08 | 업그레이드 | Stifel | Hold → Buy |
| 2017-10-19 | 개시 | FBR & Co. | Buy |
| 2017-09-19 | 다운그레이드 | Stifel | Buy → Hold |
| 2017-07-17 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-07-14 | 개시 | Janney | Neutral |
| 2017-06-01 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2016-07-18 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2016-07-18 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2016-02-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2015-11-05 | 재확인 | Northland Capital | Outperform |
| 2015-10-28 | 개시 | Northland Capital | Outperform |
모두보기
Supernus Pharmaceuticals Inc 주식(SUPN)의 최신 뉴스
Statistical indicators supporting Supernus Pharmaceuticals Inc.’s strengthDollar Strength & High Return Stock Watch Alerts - newser.com
Is Supernus Pharmaceuticals Inc. a candidate for recovery play2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Top chart patterns to watch in Supernus Pharmaceuticals Inc.Stop Loss & Weekly Top Stock Performers List - newser.com
Why Supernus Pharmaceuticals Inc. stock remains undervaluedWeekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Can Supernus Pharmaceuticals Inc. stock continue upward trendJuly 2025 Momentum & Expert Curated Trade Setup Alerts - newser.com
Supernus Pharmaceuticals Inc. stock trendline breakdownEarnings Recap Report & Low Risk High Win Rate Stock Picks - newser.com
Using data models to predict Supernus Pharmaceuticals Inc. stock movementBuy Signal & Verified Short-Term Plans - newser.com
Long term hold vs stop loss in Supernus Pharmaceuticals Inc.Bear Alert & Technical Analysis for Trade Confirmation - newser.com
Supernus Pharmaceuticals (SUPN) Reports Q3: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? - MSN
Is Supernus Pharmaceuticals Inc. stock near bottom after declineEntry Point & Stepwise Trade Signal Implementation - newser.com
Advanced analytics toolkit walkthrough for Supernus Pharmaceuticals Inc.2025 Support & Resistance & Verified Short-Term Trading Plans - newser.com
Is Supernus Pharmaceuticals Inc. stock attractive after correctionJuly 2025 PostEarnings & Technical Pattern Alert System - newser.com
How to monitor Supernus Pharmaceuticals Inc. with trend dashboardsRisk Management & Smart Swing Trading Techniques - newser.com
Supernus Pharmaceuticals Advances ADHD Treatment Study in Young Children - MSN
What institutional flow reveals about Supernus Pharmaceuticals Inc.Weekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
Supernus Pharmaceuticals Inc expected to post earnings of 28 cents a shareEarnings Preview - TradingView
Supernus Pharmaceuticals (SUPN): Is the Recent Rally Reflected in Its Valuation? - Sahm
Supernus Pharmaceuticals Hits New 52-Week High of $57.65 - Markets Mojo
Supernus a new buy at BofA on 'underappreciated' CNS assets - MSN
How Supernus Pharmaceuticals Inc. stock reacts to Fed rate cutsPortfolio Performance Summary & Short-Term Swing Trade Alerts - newser.com
Sentiment analysis tools applied to Supernus Pharmaceuticals Inc.Market Growth Summary & Fast Gain Swing Trade Alerts - newser.com
Supernus Pharmaceuticals, Inc. (SUPN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Supernus Pharmaceuticals Hits New 52-Week High of $55.95 - Markets Mojo
Supernus Pharmaceuticals (SUPN) Price Target Increased by 32.88% to 59.36 - MSN
Supernus Pharmaceuticals, Inc. (SUPN) Stock forecasts - Yahoo! Finance UK
Supernus Pharmaceuticals Inc Stock Analysis and ForecastQuarterly Earnings Review & Rapid Portfolio Appreciation - earlytimes.in
Supernus Pharmaceuticals, Inc. (SUPN) Stock Forecasts - Yahoo! Finance Canada
Supernus Pharmaceuticals (SUPN) Gains Market Attention with Key CNS Drugs - GuruFocus
Here's Why Supernus Pharmaceuticals (SUPN) is a Great Momentum Stock to Buy - sharewise.com
Can Supernus Pharmaceuticals Sustain Momentum After 13% Jump on Neuroscience Pipeline News? - Yahoo Finance
Supernus Pharmaceuticals Hits New 52-Week High of $53.28 - Markets Mojo
BofA Securities Initiates Supernus Pharmaceuticals at Buy With $65 Price Target - MarketScreener
B of A Securities Initiates Coverage on SUPN with a Buy Rating | - GuruFocus
Supernus Pharmaceuticals Inc (SUPN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Supernus Pharmaceuticals Inc 주식 (SUPN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Khattar Jack A. | President, CEO |
Oct 09 '25 |
Sale |
50.57 |
59,900 |
3,029,336 |
1,206,578 |
| NEWHALL CHARLES W III | Director |
Oct 09 '25 |
Sale |
50.77 |
25,000 |
1,269,234 |
104,644 |
3.60%
0.45%
자본화:
|
볼륨(24시간):